Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.50 is 159% above its 5-year average of 1.35, near the low end of its 5-year range (0.04–16.05).
As of the fiscal period ended Tuesday, June 30, 2026. 75.12% above its 12-month average of 2.00.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.50.
CURRENT RATIO
3.50
CURRENT RATIO AVG TTM
2.00
CURRENT RATIO AVG 3Y
1.47
CURRENT RATIO AVG 5Y
1.35
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+75.12%
CURRENT VS 3Y AVG
+138.81%
CURRENT VS 5Y AVG
+158.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
+4.48%
vs the sector median at left
Market Cap
$61.77M
Current Ratio
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$67.11M
Current Ratio
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $63.98M | 3.50 | 2.00 | 1.47 | 1.35 |
| InterCure Ltd. (INCR)vs › | $64.56M | 1.48 | 1.60 | 1.69 | 1.84 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | 0.53 | 4.76 | 5.20 | 7.10 |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | 10.98 | 17.43 | 9.10 | 12.08 |
| Alps Group Inc (ALPS)vs › | $64.90M | 0.36 | 0.31 | 0.29 | 1.05 |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | 0.57 | 2.81 | 4.44 | 7.47 |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.78M | 1.23 | 0.89 | 0.93 | 1.06 |
| Adicet Bio, Inc. (ACET)vs › | $60.95M | 6.71 | 8.38 | 9.61 | 10.03 |
| Fractyl Health, Inc. (GUTS)vs › | $60.29M | 3.15 | 4.21 | 4.67 | 4.26 |
| Champions Oncology, Inc. (CSBR)vs › | $68.91M | 1.03 | 0.95 | 0.86 | 0.95 |
Current Ratio
3.50
Quick Ratio
3.50
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.50 |
| 2026-03-31 | 2.55 |
| 2025-12-31 | 1.16 |
| 2025-09-30 | 1.26 |
| 2025-06-30 | 1.52 |
| 2025-03-31 | 1.87 |
| 2024-12-31 | 2.55 |
| 2024-09-30 | 7.35 |
| 2024-06-30 | 1.23 |
| 2024-03-31 | 1.21 |
| 2023-12-31 | 0.04 |
| 2023-09-30 | 0.51 |
| 2023-06-30 | 0.19 |
| 2023-03-31 | 0.56 |
| 2022-12-31 | 1.12 |
| 2022-09-30 | 1.85 |
| 2022-06-30 | 10.94 |
| 2022-03-31 | 8.94 |
| 2021-12-31 | 16.05 |
| 2021-09-30 | 1.10 |
| 2021-06-30 | 0.79 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.53 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
